Asthma and Respiratory Disorders News

Sandhya Khurana, MD, FCCP, spoke with Healio about important highlights in the asthma space presented at CHEST 2022.

LOUISVILLE, Ky. — Of approved biologics for severe, allergic asthma, tezepelumab was the only one to consistently reduce the annualized exacerbation rate across patient subgroups, according to a literature review.

LOUISVILLE, Ky. — In this Healio exclusive, Brian T. Kelly, MD, MA, FACAAI, program chair of the American College of Allergy, Asthma & Immunology Annual Scientific Meeting, highlights key sessions and themes of this year’s meeting.

LOUISVILLE, Ky. — Liability concerns prevent stakeholders from adequately stocking albuterol inhalers in Illinois schools, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

LOUISVILLE, Ky. — Much like exercise-induced asthma, sexual intercourse can also trigger asthma exacerbations, according to study results presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The FDA’s Pulmonary-Allergy Drug Advisory Committee voted 16-1 in favor of approving the fixed-dose combination of budesonide and albuterol sulfate metered dose inhaler for patients with asthma aged 18 years and older.

The numbers of new cases of childhood asthma significantly fell during the COVID-19 pandemic in Japan, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The prevalence of chronic rhinosinusitis with nasal polyps grew in Finland from 2012 to 2019, with asthma increasing patients’ need for corticosteroids and surgery, according to a study published in Clinical and Translational Allergy.

The maternal diet index appeared superior to other measurements in predicting childhood allergic disease among offspring, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.